Tech Company Financing Transactions
NutriSense Funding Round
On 7/14/2022, NutriSense raised $25 million in Series A funding from 1315 Capital.
Transaction Overview
Company Name
Announced On
7/14/2022
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
1315 Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to grow their operational team and to expand outreach to new members.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
222 West Merchandise Mart Plaza 1212
Chicago, IL 60654
USA
Chicago, IL 60654
USA
Phone
Website
Email Address
Overview
NutriSense is a platform focused on improving metabolic health. Our mission is to help anybody discover and reach their health potential. Our members discover the perfect diet for their unique bodies by tracking key metabolic markers in real-time. We leverage powerful hardware (CGM, Ketone Meters, etc), software, and a team of expert dietitians to enable lasting behavior change. We provide the tools and support our members need to make smarter food and lifestyle decisions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Skryl
Chief Marketing Officer
Pavel Sokolovsky
Chief Operating Officer
Dan Zavorotny
VP - Engineering
Ivan Spogreev
VP - Operations
Katie Olsen
Browse more venture capital transactions:
Prev: 7/14/2022: Stimdia Medical venture capital transaction
Next: 7/14/2022: Manifold Bio venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs